NFE2L2 and neuroblastoma: In the study of Wang et al. (2008), stable overexpression or induced upregulation of Nrf2 in SH-SY5Y neuroblastoma cells was reliably linked to enhanced resistance to cisplatin, etoposide and doxorubicin, which are utilized in the treatment regimen for high-risk neuroblastoma [30,31].